fbpx

The Pandemic Portfolio – Update 5

On March 25th we published our Pandemic Portfolio of 24 stocks we thought would benefit from the new remote economy.

It has been a while since we looked at them so we thought it was time to check in again and see how they have performed. The table below shows the gain/(loss) since we first published on March 25th 2020.

The recent market pull-back offers investors a chance to enter into this positions if you haven’t already

Ticker Company Industry Gain/loss
CLX Clorox Bleach/Wipes +27.68%
GILD Gilead Corona Treatments -10.64%
REGN Regeneron Corona Treatments +33.57%
TDOC Teladoc Digital Doctor Visits +54.11%
WORK Slack Digital Workforce +5.29%
ZM Zoom Video Digital Workforce +259.50%
PTON Peleton Home Exercise +298.57%
CHGG Chegg Online Education +104.70%
TWTR Twitter Online News +68.61%
PETS 1-800-PetMeds Online Pet Healthcare +22.44%
CHWY Chewy Online Pet Shopping +80.24%
AMZN Amazon Online Shopping +64.12%
FB Facebook Social +63.13%
CPB Campbell Soup Staples Food +14.85%
HRL Hormel Staples Food +16.45%
JNJ Johnson & Johnson Staples Health +21.99%
PG Proctor & Gamble Staples Health +36.37%
NFLX Netflix Streaming Content +41.03%
ATVI Activision Video Games +53.17%
EA Electronic Arts Video Games +46.35%
TTWO Take-Two Video Games +51.09%
AKAM Akami Tech Internet Infrastructure +24.76%
ELY Callaway Golf <10 person leisure +81.09%
HD Home Depot Home Improvement +47.75%

All stocks except Gilead Science (GILD) are showing gains with some extremely impressive. As at today’s date the average gain is +62.77% and this portfolio is easily one of the best performing list of stocks we have seen in some time.

You can read prior updates to this portfolio at these below links

The Pandemic Portfolio

The Pandemic Portfolio – Update

The Pandemic Portfolio – Update 2

The Pandemic Portfolio – Update 3

The Pandemic Portfolio – Update 4

Disclaimer: Capital 19 Pty Ltd ABN 17 124 264 366 AFSL 441891 (‘Capital 19’) believes the information contained is reliable, however, no warranty is given as to its accuracy and persons relying on this information do so at their own risk. This communication is for general information only and was prepared for multiple distributions and does not take account of the specific investment objectives of individual recipients and it may not be appropriate in all circumstances. Persons relying on this information should do so considering their specific investment objectives and financial situations. Any person considering action based on this communication must seek individual advice relevant to their circumstances and investment objectives. Subject to any liability which cannot be excluded under the relevant laws. Any opinions or forecasts reflect the judgment and assumptions of Capital 19 and its representatives based on information at the date of publication and may later change without notice. Any projections contained in this presentation are estimates only and may not be realised in the future. The investment manager certifies that all the views expressed in this document accurately reflect their views about the companies and securities referred to in this document and that their remuneration is not directly or indirectly related to the views. Capital 19, its directors, representatives, employees or related parties may have an interest in any of the companies and securities in this document and may earn revenue from the sale or purchase of any financial product referred to in this document or any advice. Past performance is not a reliable indicator of future performance. Unauthorised use, copying, distribution, replication, posting, transmitting, publication, display, or reproduction in whole or in part of the information contained in this document is prohibited without obtaining prior written permission from Capital 19.
Tags: